Metagenomic Sequencing Market Dimension is projected to succeed in USD 5.78 Billion by 2030, rising at a CAGR of 17.5%: Straits Analysis

New York, United States, July 13, 2022 (GLOBE NEWSWIRE) — Metagenomics is a molecular software in genomics that analyses blended genomic supplies extracted from a group of organisms utilizing metagenomics sequencing. Metagenomics permits researchers to review organisms which might be troublesome to tradition within the lab. As a result of most microorganisms have by no means been cultured, together with most of them. “metagenomic sequencing” refers to a radical examination of all organisms recovered from the surroundings.

Microbes in varied settings could be recognized and quantified utilizing metagenomics sequencing. It’s additionally a possibility to analysis unculturable microorganisms and study their organic potential. Developments in metagenomics sequencing, vital functions of metagenomics in varied fields, initiatives and funding from authorities and personal our bodies for large-scale sequencing initiatives, and a lower in sequencing price are driving the market development.

Get a Free Pattern Copy of This Report @

Advances in Metagenomic Sequencing to Drive the World Metagenomic Sequencing Market

Technological developments have allowed metagenomic sequencing platforms to make vital progress lately. Because of varied components similar to low enter pattern focus necessities, lack of experimental bias in microarrays, and others, DNA sequencing is way extra useful and advantageous than conventional microarrays. The overall variety of produced sequence reads per run has skyrocketed with the arrival of huge parallelization of sequencing reactions.

Specialists worldwide are searching for an appropriate platform that reduces the variety of pre-sequencing steps, ensures genuine sequences with lengthy reads (MB to GB) produced per run, works on a DNA molecule with out pre-amplification and has excessive learn accuracy. In consequence, scientists are concentrating on creating superior sequencing platforms. As a result of DNA sequencing is carefully linked to metagenomics analysis, developments on this space are anticipated to contribute to market development.

Report Scope

Report Metric Particulars
Market Dimension USD 5.78 Billion by 2030
CAGR 17.5% (2022-2030)
Historic Knowledge 2019-2020
Base 12 months 2021
Forecast Interval 2022-2030
Forecast Items Worth (USD Billion)
Report Protection Income Forecast, Aggressive Panorama, Development Elements, and Developments
Segments Coated By Product and Service, By Expertise, By Software, By Areas
Geographies Coated North America, Europe, Asia-Pacific, LAME and Remainder of the World
Key Firms Profiled/Distributors BGI Genomics Co., Ltd., Oxford Nanopore Applied sciences Ltd, Eurofins Genomics, Illumina, Inc., Macrogen Inc., Pacific Biosciences of California, Inc., PerkinElmer Inc.,
QIAGEN N.V., Swift Biosciences Inc., Thermo Fisher Scientific Inc.
Key Market Alternatives Availability of Cloud Computing for Knowledge Administration
Key Market Drivers Growth in Metagenomic Sequencing
Vital Purposes of Metagenomics in Numerous Fields

Purchase Now Full Report @

Availability of Cloud Computing for Knowledge Administration to Present Profitable Alternatives for the World Metagenomic Sequencing Market

With elevated consciousness in growing economies, the demand for metagenomic sequencing applied sciences has grown in scientific communities worldwide. However, cloud computing provides a tormenting possibility for on-demand entry to computing sources for metagenomics sequencing. Moreover, in bioinformatics and computational biology, an important native alignment search software (BLAST) on correct metagenomics knowledge in a cloud surroundings to evaluate the viability of metagenomic sequencing strategies, BLAST is among the most acceptable functions. It’s assumed to devour the vast majority of sources in that space. In consequence, alternatives similar to cloud computing for knowledge administration are propelling the worldwide metagenomic sequencing market ahead. 

Regional Insights

North America dominated the market. It’s estimated to succeed in an anticipated worth of USD 2,035 million by 2030 at a CAGR of 17%. The USA, Canada, and Mexico are the three main international locations studied in North America. Due to its stronghold on deoxyribonucleic acid (DNA) sequencing applied sciences, the Area accounted for the most important share within the international metagenomic sequencing market, owing to the Area’s steady enchancment, availability, and accessibility of DNA sequencing.

In North America, a number of worldwide producers of DNA sequencing, platforms, tools, and applied sciences are very energetic. Vital gamers try to introduce inexpensive DNA sequencing applied sciences within the North American market. This has given the worldwide metagenomics market on this Area a lift, permitting researchers to dig deeper into the microbial ecology. Moreover, the North American market has seen vital developments in the usage of metagenomics merchandise and applied sciences in biotechnology, that are anticipated to open up new avenues and supply quite a few alternatives for market enlargement.

The Asia-Pacific area is anticipated to develop the quickest. With a CAGR of 19%, it’ll attain USD 1,270 million by 2030. Japan, China, Australia, India, and the remainder of Asia-Pacific are all studied on this report. The surge within the focus of healthcare professionals towards drug discovery and development within the biotechnology trade has given Asia-Pacific large potential for metagenomics development. Moreover, the elevated availability of novel superior sequencing applied sciences throughout this Area’s international locations is anticipated to contribute to the very best development fee through the forecast interval.

Key Highlights

  • The international metagenomic sequencing market was value USD 1,355 million in 2021 and is anticipated to succeed in USD 5,785 million by 2030, rising at a CAGR of 17.5% through the forecast interval (2022–2030).
  • By product and repair, the market is categorized into reagents and consumables, devices, and companies. The companies phase generated the very best income in 2021. It’s estimated to succeed in an anticipated worth of USD 3,830 million by 2030 at a CAGR of 17.6%. The excessive market development is attributed to the upper adoption of metagenomic sequencing companies and evaluation & knowledge interpretation options. 
  • By know-how, the market is categorized into shotgun metagenomics sequencing, 16S rRNA sequencing, whole-genome sequencing and de novo meeting, and metatranscriptomics. The 16S rRNA sequencing phase led the market in 2021. It’s estimated to succeed in an anticipated USD 2,300 million by 2030 at a CAGR of 17.6%.
  • By software, the market is classed into drug discovery, ecological and environmental metagenomics, medical diagnostics, biofuel, and industrial. The drug discovery phase was the most important software phase out there in 2021. It’s estimated to succeed in an anticipated worth of USD 2,120 million by 2030 at a CAGR of 18.3%. Elements like the event and commercialization of drug discovery for unknown pathogenic organisms are anticipated to drive the expansion of the drug discovery phase within the coming years.

Get a Free Pattern Copy of This Report @

Aggressive Evaluation

  • BGI Genomics Co., Ltd.
  • Oxford Nanopore Applied sciences Ltd
  • Eurofins Genomics
  • Illumina, Inc.
  • Macrogen Inc.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher Scientific Inc. 

World Metagenomic Sequencing Market: Segmentation

By Product and Service

  • Reagents and Consumables
  • Instrument
  • Providers 

By Expertise 

  • Shotgun Metagenomic Sequencing
  • 16s rRNA Sequencing
  • Complete Genome Sequencing and De Novo Meeting
  • Metatranscriptomics

By Software 

  • Drug Discovery
  • Ecological and Environmental Metagenomics
  • Scientific Diagnostics
  • Biofuel
  • Industrial Purposes

By Areas 

  • North America
  • Europe
  • Asia-Pacific


1          Introduction

1.1      Market Definition

1.2      Market Scope

2          Analysis Methodology

2.1      Major Analysis

2.2      Analysis Methodology

2.3      Assumptions & Exclusions

2.4      Secondary Knowledge Sources

3          Government Abstract

4          Market Overview

4.1      Report Segmentation & Scope

4.2      Worth Chain Evaluation: Metagenomic Sequencing Market

4.2.1  Vendor Matrix

4.3      Key Market Developments

4.3.1  Drivers

4.3.2  Restraints

4.3.3  Alternatives

4.4      Porter’s 5 Forces Evaluation

4.4.1  Bargaining Energy of Suppliers

4.4.2  Bargaining Energy of Patrons

4.4.3  Risk of Substitution

4.4.4  Risk of New Entrants

4.4.5  Aggressive Rivalry

4.5      Surroundings & Regulatory Panorama

4.6      Forecast Elements & Relevance of Influence

4.7      Macro-Financial & Geopolitical State of affairs

4.8      Dad or mum Market Overview

4.9      Expertise Panorama

4.10   Market Share Evaluation

4.11   Potential Enterprise Evaluation

4.12   Regional Value Developments

4.13   Uncooked Materials Developments

4.14   Value Construction Evaluation

4.14.1            Labor Value

4.14.2            Consumables

4.14.3            Upkeep Value

4.15   Covid-19 Influence Evaluation:

4.15.1            Pre and Publish Covid-19 Market State of affairs Evaluation

4.15.2            Market Restoration Timeline and Problem

4.15.3            Measures Taken by High Gamers

4.15.4            Quarterly Market Income and Development Forecast until 2021        North America        Europe        Asia-Pacific        Central and South America and the Caribbean        The Center East and Africa

5               Product And Providers Overview

5.1      Introduction

5.1.1  Market Dimension & Forecast (Worth & Quantity)

5.2      Reagents and Consumables

5.2.1  Market Dimension & Forecast (Worth & Quantity)

5.3      Instrument

5.3.1  Market Dimension & Forecast (Worth & Quantity)

5.4      Providers

5.4.1  Market Dimension & Forecast (Worth & Quantity)

6               Expertise Overview

6.1      Introduction

6.1.1  Market Dimension & Forecast (Worth & Quantity)

6.2      Shotgun Metagenomic Sequencing

6.2.1  Market Dimension & Forecast (Worth & Quantity)

6.3      16s rRNA Sequencing

6.3.1  Market Dimension & Forecast (Worth & Quantity)

6.4      Complete Genome Sequencing and De Novo Meeting

6.4.1  Market Dimension & Forecast (Worth & Quantity)

6.5      Metatranscriptomic

6.5.1  Market Dimension & Forecast (Worth & Quantity)

7               Purposes Overview

7.1      Introduction

7.1.1  Market Dimension & Forecast (Worth & Quantity)

7.2      Drug Discovery

7.2.1  Market Dimension & Forecast (Worth & Quantity)

7.3      Ecological and Environmental Metagenomics

7.3.1  Market Dimension & Forecast (Worth & Quantity)

7.4      Scientific Diagnostics

7.4.1  Market Dimension & Forecast (Worth & Quantity)

7.5      Biofuel

7.5.1  Market Dimension & Forecast (Worth & Quantity)

7.6      Industrial Purposes

7.6.1  Market Dimension & Forecast (Worth & Quantity)

8             Regional Overview

8.1      Introduction

8.1.1  Market Dimension & Forecast (Worth & Quantity)

8.2      North America

8.2.1  Financial Overview

8.2.2  Market State of affairs

8.2.3  U.S.

8.2.4  Canada

8.2.5  Mexico

8.3      Central and South America and the Caribbean

8.3.1  Financial Overview

8.3.2  Market State of affairs

8.3.3  Brazil

8.3.4  Argentina

8.3.5  Colombia

8.3.6  Remainder of Central and South America and the Caribbean

8.4      Europe

8.4.1  Financial Overview

8.4.2  Market State of affairs

8.4.3  Germany

8.4.4  France

8.4.5  The U.Ok.

8.4.6  Italy

8.4.7  The Relaxation Of Europe

8.5      Asia-Pacific (APAC)

8.5.1  Financial Overview

8.5.2  Market State of affairs

8.5.3  China

8.5.4  Japan

8.5.5  India

8.5.6  Australia

8.5.7  South Korea

8.5.8  Relaxation Of APAC

8.6      Center East

8.6.1  Financial Overview

8.6.2  Market State of affairs

8.6.3  South Arabia

8.6.4  The UAE

8.6.5  Qatar

8.6.6  Oman

8.6.7  Turkey

8.6.8  The Relaxation Of Center East

8.7      Africa

8.7.1  Financial Overview

8.7.2  Market State of affairs

8.7.3  Nigeria

8.7.4  South Africa

8.7.5  The Relaxation Of Africa

9          Aggressive Panorama — Producers & Suppliers

9.1      Competitors Dashboard

9.2      Trade Construction

9.3      BGI Genomics Co., Ltd.

9.3.1  Enterprise Overview

9.3.2  Monetary Efficiency

9.3.3  Current Developments

9.3.4  Portfolio

9.4      Oxford Nanopore Applied sciences Ltd

9.5      Eurofins Genomics

9.6      Illumina, Inc.

9.7      Macrogen Inc.

9.8      Pacific Biosciences of California, Inc.

9.9      PerkinElmer Inc.

9.10   QIAGEN N.V.

9.11   Swift Biosciences Inc.

9.12   Thermo Fisher Scientific Inc.

10       Conclusion & Advice

11       Acronyms & Abbreviations

Desk of Content material and Determine @

Market Information

  • In June 2021, Illumina introduced an settlement with the Belgian Genetic Facilities to judge whole-genome sequencing (WGS) for the analysis of sufferers with mental disabilities (ID) and developmental issues (DD).
  • In April 2021 – Illumina introduced a partnership with Kartos Therapeutics, Inc. to co-develop a tumor protein (TP53) companion diagnostic (CDx) based mostly on Illumina’s complete genomic profiling content material assay, TruSight Oncology. It should develop the TruSight Oncology choices into hematologic malignancies of illumine
  • In February 2021 – PacBio introduced that Youngsters’s Mercy Kansas Metropolis elevated its funding in extremely correct HiFi sequencing with 4 new Sequel IIe Methods so as to add to its two present Sequel IIe Methods.

Information Media

The Tangential Movement Filtration Market to Profit from the Widescale Adoption of Single-Use Applied sciences

Molecular Diagnostics Market: Way forward for Early Illness Detection

North America to Dominate the Lengthy Learn Sequencing Market

Have a Have a look at the Associated Analysis Report    

NGS-based RNA-Sequencing Market: Info by Product and Providers (Pattern Preparation), Expertise (Nanopore), Software (Epigenetics), Finish-Consumer, and Area — Forecast until 2029

Subsequent-Technology Sequencing Market: Info by Product (Consumables, Platforms), Software (Reproductive Well being, Cardiovascular, Others), Finish-Customers, and Area — Forecast until 2029

Lengthy Learn Sequencing Market: Info by Expertise (Nanopore), Product (Consumable), Software (Most cancers), Work Movement (Sequencing), Finish-Consumer (Clinics), and Area—Forecast until 2029

Botanical Medication Market : Info by Kind (Leaves, Stem/Bark), Type (Pill, Ointment, Spray, Oral Resolution), Software (Prescribed drugs, Dermatology), and Area — Forecast until 2030

Organic Security Testing Merchandise and Providers Market: Info by Product (Take a look at Kits and Reagents), Take a look at (Endotoxin Take a look at, Adventitious Agent), and Area — Forecast until 2029

Immunotherapy Medication Market: Info by Kind (Monoclonal Antibodies), Therapeutic Space (Most cancers), Finish-Consumer (Hospital), and Area — Forecast until 2029

Biosensors Market: Info by Expertise (Thermal, Electrochemical), Software (Medical, Meals Toxicity), Finish-Consumer (Dwelling Healthcare Diagnostics), and Area — Forecast until 2030

About Straits Analysis Pvt. Ltd.

StraitsResearch is a market intelligence firm offering international enterprise data stories and companies. Our unique mix of quantitative forecasting and developments evaluation gives forward-looking perception for hundreds of decision-makers. Straits Analysis Pvt. Ltd. gives actionable market analysis knowledge, particularly designed and offered for determination making and ROI.

Whether or not you’re looking at enterprise sectors within the subsequent city or crosswise over continents, we perceive the importance of being acquainted with the consumer’s buy. We overcome our shoppers’ points by recognizing and deciphering the goal group and producing leads with utmost precision. We search to collaborate with our shoppers to ship a broad spectrum of outcomes via a mix of market and enterprise analysis approaches.

For extra data in your goal market, please contact us under:

Cellphone: +1 646 480 7505 (the U.S.)

+91 8087085354 (APAC)

+44 208 068 9665 (the U.Ok.)

Electronic mail: [email protected]

Observe Us: LinkedIn | Fb | Instagram | Twitter

Keep linked with us on social media platform for instantaneous replace click on right here to hitch our  Twitter, & Fb